75. Cushing disease Clinical trials / Disease details
Clinical trials : 203 / Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04339751 (ClinicalTrials.gov) | March 24, 2022 | 8/4/2020 | Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease | The Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing's Disease | Cushing's Disease | Drug: Vorinostat | National Institute of Neurological Disorders and Stroke (NINDS) | NULL | Not yet recruiting | 18 Years | N/A | All | 22 | Phase 2 | United States |